Overall, the analysis with OCA predicted the up-regulation of TFs related to the inhibition of HSC activation responsible for the collagen deposition in liver tissue during fibrogenesis (49), along with TFs described as protective against inflammatory response and hepatic fat deposition, and down-regulation of TF signatures of steatosis, fibrosis and HCC. The gene discussed is TF; the disease is hepatocellular carcinoma.